OMIP 071: A 31‐Parameter Flow Cytometry Panel for In‐Depth Immunophenotyping of Human T‐Cell Subsets Using Surface Markers

Dissecting the functional diversity of T cells is critical in elucidating mechanisms and in developing therapies for various diseases. Here, we designed a 31‐parameter (29‐color) panel to enable the characterization of T‐cell subsets and immunophenotyping of the human peripheral blood and lymph node...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 99; no. 3; pp. 273 - 277
Main Authors Wang, Song‐Rong, Zhong, Na, Zhang, Xin‐Mei, Zhao, Zhi‐Bin, Balderas, Robert, Li, Liang, Lian, Zhe‐Xiong
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.03.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dissecting the functional diversity of T cells is critical in elucidating mechanisms and in developing therapies for various diseases. Here, we designed a 31‐parameter (29‐color) panel to enable the characterization of T‐cell subsets and immunophenotyping of the human peripheral blood and lymph nodes using cell surface staining. In addition to adaptive T‐cell markers, TCR Vα24‐Jα18, TCR γδ, TCR Vɑ7.2, and CD161 were included to identify iNKT, γδ T, and MAIT cells, respectively, which are innate‐like T cells. C‐X‐C chemokine receptors (CXCR3, CXCR4, CXCR5, CXCR6) and C‐C motif chemokine receptors (CCR4, CCR6, CCR7) were included to enable the identification of Th cell subsets (Th1, Th2, Th17), Tfh cell subsets (Tfh1, Tfh2, Tfh17), and Th cells with specific homing capacities. Furthermore, in this panel, we also used markers for assessing cell differentiation (CD45RO, CD7), activation (CD57, CD95, HLA‐DR) and the expression of some cosignaling molecules (PD‐1, NKG2D, CD28). Particularly, CD69 and CD103 were included for the further analysis of tissue resident memory T (Trm) cells. This panel would enable the in‐depth immunophenotyping of human T‐cell subsets, and may be applied in the monitoring, prognosis, and mechanistic studies of various immune‐related diseases.
Bibliography:Funding information
China Postdoctoral Science Foundation, Grant/Award Numbers: 2018M643095, 2019M650201; National Natural Science Foundation of China, Grant/Award Numbers: 81801607, 81901652; Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Grant/Award Number: 2018GZR110102001; Program for Guangdong Introducing Innovative and Enterpreneurial Teams, Grant/Award Number: 2017ZT07S054
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1552-4922
1552-4930
1552-4930
DOI:10.1002/cyto.a.24272